Establishment Labs (NASDAQ:ESTA) Trading 7.2% Higher - Here's What Happened

Key Points

• Establishment Labs shares rose 7.2% to about $81 in Friday midday trading, although volume was roughly 80% below the average session level.
• Analyst sentiment is broadly positive: Citigroup upgraded the stock to “buy,” while several firms raised their price targets. Eight analysts rate it a Buy versus one Sell, with a consensus target of $100.25.
• The company’s latest quarterly revenue increased 31.7% year over year to $67.54 million, beating estimates, but EPS of -$0.39 missed expectations; the company remains unprofitable with a negative net margin.

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) shares were up 7.2% on Friday . The company traded as high as $81.18 and last traded at $81.02. 112,510 shares changed hands during mid-day trading, a decline of 80% from the average session volume of 553,757 shares. The stock had previously closed at $75.59.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Citigroup upgraded shares of Establishment Labs from a "neutral" rating to a "buy" rating and set a $92.00 price objective on the stock in a research report on Thursday. TD Cowen upped their price objective on Establishment Labs from $95.00 to $117.00 and gave the stock a "buy" rating in a report on Monday, August 3rd. BTIG Research increased their price objective on Establishment Labs from $96.00 to $103.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Mizuho increased their price objective on Establishment Labs from $100.00 to $105.00 and gave the company an "outperform" rating in a research report on Wednesday, July 15th. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of Establishment Labs in a report on Wednesday, June 24th. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Establishment Labs has an average rating of "Moderate Buy" and a consensus target price of $100.25.

Establishment Labs Stock Performance

The company has a debt-to-equity ratio of 16.82, a quick ratio of 1.91 and a current ratio of 2.96. The company has a market cap of $2.39 billion, a PE ratio of -61.24 and a beta of 1.07. The business's 50-day moving average is $86.69 and its 200 day moving average is $74.54.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.05). The business had revenue of $67.54 million for the quarter, compared to analysts' expectations of $65.79 million. Establishment Labs had a negative net margin of 15.82% and a negative return on equity of 205.79%. The business's quarterly revenue was up 31.7% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.57) earnings per share. On average, equities research analysts predict that Establishment Labs Holdings Inc. will post -1.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Establishment Labs

Large investors have recently bought and sold shares of the stock. KBC Group NV bought a new position in shares of Establishment Labs in the first quarter worth approximately $28,000. Quarry LP purchased a new stake in Establishment Labs during the 3rd quarter valued at $34,000. Northwestern Mutual Wealth Management Co. purchased a new stake in Establishment Labs during the 2nd quarter valued at $43,000. Kestra Advisory Services LLC purchased a new stake in Establishment Labs during the 4th quarter valued at $47,000. Finally, Osaic Holdings Inc. grew its holdings in Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company's stock worth $85,000 after acquiring an additional 1,800 shares during the last quarter. 72.91% of the stock is owned by hedge funds and other institutional investors.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company's proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company's flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source